Comparative Study to Evaluate KADIAN and Avinza in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00782548
Recruitment Status : Completed
First Posted : October 31, 2008
Last Update Posted : October 31, 2008
Information provided by:
Alpharma Pharmaceuticals LLC, a subsidiary of Pfizer Inc.

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2004
  Actual Study Completion Date : June 2004

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 December 8, 2008
January 6, 2009
2 July 21, 2009
August 31, 2009
3 November 18, 2009
December 15, 2009
4 December 15, 2009
January 15, 2010
5 August 13, 2010
September 8, 2010